Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 96329

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 24, 2025
Product types
Drug
Classifications
Class III
Statuses
Ongoing
Recalling firm wording
Imprimis NJOF, LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC: 71384-733-05.

D-0305-2025
Recall number
D-0305-2025
Initiated
February 24, 2025
Classification
Class III
Status
Ongoing
Recalling firm
Imprimis NJOF, LLC
Quantity
2822 bottles

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
subpotent

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.

Code information

Lot 24OCT041, Exp 04/26/2025

Distribution pattern

FL and NY